Apr 6, 2024, 10:04
Jean Zeghondy: Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open
Jean Zeghondy, Associate Practitioner at the Breast Cancer Unit at Gustave Roussy, shared a post on LinkedIn:
“Our work on Tucatinib combination post Trastuzumab-Deruxtecan in HER2+ Metastatic Breast Cancer published in JAMA Network Open.”
Read further.
Source: Jean Zeghondy/LinkedIn